The concentrations of both somatostatin-like immunoreactivity (SLI) and neuropeptide Y-like immunoreactivity (NPYLI) were measured in all major cortical and subcortical regions of monkey brain. High concentrations of both SLI and NPYLI were found in cerebral cortex where they were significantly correlated, supporting a colocalization of the two peptides in cortical neurons. There were no significant differences between the right and left hemispheres. Subdissections of the basal ganglia showed that concentrations of both SLI and NPYLI were 3-fold higher in the nucleus accumbens than in the remainder of the striatum, where concentrations of the peptides were evenly distributed. SLI and NPYLI levels were significantly correlated in the striatum, supporting a colocalization of the two neuropeptides in striatal neurons. Concentrations were low in the globus pallidus. Limbic system nuclei including the amygdala, bed nucleus of the stria terminalis and substantia innominata had relatively high concentrations of both SLI and NPYLI. In several subcortical regions concentrations of the neuropeptides were dissociated, suggesting separate neuronal populations. The distribution of both neuropeptides in monkey brain closely resembles that in human brain. The high levels in cerebral cortex and basal ganglia suggest that somatostatin and neuropeptide Y may play a role both in cognition and in normal motor function.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0006-8993(87)90290-3DOI Listing

Publication Analysis

Top Keywords

sli npyli
16
monkey brain
12
concentrations sli
12
somatostatin neuropeptide
8
subcortical regions
8
brain high
8
high concentrations
8
cerebral cortex
8
supporting colocalization
8
basal ganglia
8

Similar Publications

We have measured cerebrospinal fluid (CSF) neuropeptide Y-like immunoreactivity (NPY-LI) and somatostatin-like immunoreactivity (SLI) in control subjects and in patients with various neurologic disorders. We observed a significant reduction in CSF SLI in control subjects over 60 years of age, compared with the younger controls. CSF SLI was significantly decreased in multiple sclerosis (MS), or Guillain-Barre syndrome, compared with that of age-matched control subjects.

View Article and Find Full Text PDF

Somatostatin-like immunoreactivity (SLI) and neuropeptide Y-like immunoreactivity (NPYLI) were measured in the cerebral cortex of 49 patients with Alzheimer's disease (AD), and 9 elderly controls. Concentrations of SLI were lower in AD patients relative to controls in 9 of 10 cortical regions. In contrast, no significant differences in NPYLI concentrations between the two groups were observed in any of 10 regions.

View Article and Find Full Text PDF

The somatostatin-like (SLI), the neuropeptide Y-like (NPY-LI), and the beta-endorphin-like (BE-LI) immunoreactivities of cerebrospinal fluid (CSF) obtained by suboccipital puncture, or plasma from patients suffering from common migraine or other neuropsychiatric disorders were analysed. The SLI concentration was tendentiously decreased in the migraine patients during the attack-free period compared to that of a 'mixed neuropsychiatric group'. During the migraine attack the level of SLI was further decreased.

View Article and Find Full Text PDF

Several neurologic illnesses in which excitotoxic mechanisms may play a role increase in prevalence with age. In the present study we examined the susceptibility of rats to quinolinic acid striatal lesions at 1, 4 and 20 months of age, and susceptibility to N-methyl-D-aspartate (NMDA) at 1 and 4 months of age. The extent of the lesions was quantitated with measurements of substance P-like immunoreactivity (SPLI) and gamma-aminobutyric acid (GABA).

View Article and Find Full Text PDF

Immunocytochemical studies utilizing radioimmunoassay and morphological techniques have provided conflicting evidence for the involvement of somatostatin and neuropeptide Y in Alzheimer's disease (AD). However, previous investigators have not considered the effects of cortical atrophy in AD tissue on their findings. This study reports the numbers of somatostatin-like (SLI) and neuropeptide Y-like immunoreactive (NPYLI) neuronal perikarya and the length of SLI and NPYLI immunoreactive fibres, with appropriate corrections for atrophy in 6 control and 6 AD cases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!